Clinical Trials in San Francisco

Showing 1241-1260 of 6,211 trials

PRO 140 in Treatment-Experienced HIV-1 Subjects

NCT03902522

The primary objectives of the trial are to assess the efficacy, clinical safety and tolerability parameters of PRO 140 in combination with failing ART (antiretroviral therapy) during the initial one-week treatment period, and in combination with Optimized Background Therapy during the subsequent 24-week treatment period.

HIV-1-infection

CytoDyn, Inc.6 participantsStarted Jun 2018

Palm Springs, California, United States • San Francisco, California, United States • New Haven, Connecticut, United States +14 more locations

COMPLETED< 1 mile

Accuracy of Pulse Oximeters With Profound Hypoxia During Motion

NCT04814342

The aim of this study is to determine the accuracy of devices called pulse oximeters, which measure blood oxygen by shining light through fingers, ears or other skin, without requiring blood sampling. Study will be used with patients during controlled motion.

Hypoxia

Nihon Kohden5 participantsStarted Mar 2021

San Francisco, California, United States

PRO 140 in Treatment-Experienced HIV-1 Subjects

Accuracy of Pulse Oximeters With Profound Hypoxia During Motion

Find Trials by Condition in San Francisco

Observe Change in Nasal Swab DRD2 Gene Expression in Restless Legs Syndrome (RLS) Patients on Prolonged Dopamine Agonist Treatment

Treatment Monitoring in Autism Spectrum Disorder (ASD) in Children

Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification

A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age

Omnipod 5 System Compared to Pump Therapy

A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

The Pediatric Artificial Pancreas Automated Initialization Trial

Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM

Safety and Effectiveness of Sonu for Pediatric Nasal Congestion

A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

Abatacept in Immune Checkpoint Inhibitor Myocarditis

Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

BlueWind RENOVA iStim™ System for the Treatment of OAB

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms

A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)

Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System